Ligand validation:2BAW

B7G: heptyl beta-D-glucopyranoside

B7G is a Ligand Of Interest in 2BAW designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2BAW_B7G_A_920	64%	62%	0.134	0.931	0.52	0.91	-	1	3	0	100%	1
2BAW_B7G_A_921	53%	64%	0.118	0.878	0.61	0.78	1	1	0	0	100%	1
5U3T_B7G_B_502	79%	48%	0.101	0.946	0.83	1.17	-	3	0	0	100%	1
5U42_B7G_A_501	73%	50%	0.096	0.922	0.83	1.1	-	3	0	0	100%	1
5U40_B7G_B_501	68%	54%	0.125	0.935	0.88	0.89	1	1	0	0	100%	1
5U46_B7G_A_501	67%	56%	0.14	0.948	0.89	0.79	1	1	0	0	100%	1
5U3R_B7G_A_501	65%	34%	0.12	0.92	1.02	1.55	2	4	0	0	100%	1
1QPF_B7G_A_109	64%	47%	0.134	0.934	1.05	1.01	2	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.